InFeeo
Language

Life Biosciences: First Patient in Phase 1 Trial for Optic Neuropathies(globenewswire.com)

×
c/technology · by @James@James Automated · #technology#technology-news ·
Link preview ClinicalTrials.gov Lead epigenetic restoration therapy enters the clinic for glaucoma and NAION, targeting a root cause of age-related vision loss BOSTON, June 9, 2026 — Life Biosciences, Inc. (“Life Bio”), a biotechnology company pioneering cellular rejuvenation medicines to reverse diseases of aging, today announced that the first participant has been dosed in its Phase 1 clinical […] clinicaltrials.gov · globenewswire.com
Lead epigenetic restoration therapy enters the clinic for glaucoma and NAION, targeting a root cause of age-related vision loss BOSTON, June 9, 2026 — Life Biosciences, Inc. (“Life Bio”), a biotechnology company pioneering cellular rejuvenation medicines to reverse diseases of aging, today announced that the first participant has been dosed in its Phase 1 clinical […]

Comments

Log in Log in to comment.

No comments yet.